Sunmax Biotechnology Co Ltd (4728.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Taiwan · ISIN TW0004728001
Sunmax Biotechnology Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.82 bn TWD | 2.03 bn TWD |
| Gross profit | 1.48 bn TWD | 1.59 bn TWD |
| Operating income | 926.96 m TWD | 998.31 m TWD |
| EBIT | 959.23 m TWD | 1.02 bn TWD |
| Net income | 679.41 m TWD | 725.75 m TWD |
| Diluted EPS – continuing operations | 12.47 TWD | 13.33 TWD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sunmax Biotechnology Co Ltd
Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.
More stocks
- Zambal Spain SOCIMI SA (YZBL.MC)
- Filtronic PLC (FTC.L)
- Shandong Meichen Science & Technology Co Ltd (300237.SZ)
- Thornburg Income Builder Opportunities Trust Common Stock (TBLD)
- Hangzhou Huawang New Material Technology Co.Ltd. (605377.SS)
- Bumble Inc. (BMBL)
- Momentum Group AB (MMGR B.ST)
- COASTAL FINANCIAL CORP (CCB)
- Formosan Union Chemical Corp (1709.TW)
- Ubisoft Entertainment SA (UBI.PA)
- KoMiCo Ltd (183300.KQ)
- Mobilezone Holding AG (MOZN.SW)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.